Member Info for benbenbenben

They have mapped out a pathway to FDA approval; will be working on the 'massive scale of opportunity in UK first' by focusing on manufacturing partners first

5-10 million tests a month as of today.

Potential to move into tens/hundreds of millions a month in near future

Pilot Batches "won't be too long now"

Will confirm "very large contract manufacturing partners" !!

Working with partners on smartphone app

"significant commercial interest in BAMS test" despite "frustrating" CONDOR program

..as has a detailed breakdown of the companies operations and is clearly privy to information we are not (as the house broker).

Can be found here - https://researchlibrary.finncap.com/Research

FYI - this was from a few weeks ago, but as mentioned elsewhere, the odds of us seeing some coverage are improving!

PSB123 - Part of mainstream news coverage of Covid.

I have no clue as to timing's, Doze, but for all we both know perhaps it was discussed yesterday, so we can hope!

A friend of mine at a major broadsheet interviewed the captain of the good ship Avacta yesterday - they know I'm invested (I told them when I tipped them off about the story) so are keeping tight lipped to maintain journalistic integrity, but I suspect we will see a story in the near future...

I'll enquire!

Timster - no mole catchers!

Seadogsteve - that is correct ;)

You can probably infer from my earlier posts in this thread what might be occuring...

@PSB123 - erm, probably best not to elaborate, just that I understand someone may have briefed a journalist and they may be speaking with someone of interest later today for a story...

Hearing that we might see some press coverage soon!

Ah thanks Ophidian - I didn't spot that one was antibody. Thanks also for your posts in general, which are very helpful to read.

As you say, if we can get 4,000 units out for evaluation then we're on - or off!

So you can see why the cost of the tooling would be an issue for a manufacturing partner - I do wonder if some of that extra funding to 'unlock' new technologies (recent government announcements) will emerge as having gone to BBI et al to allow the validation to proceed...

I suppose we shall find out!

It could be, but who would be 'they' in this instance? Public Health England + Oxford?

This government loves outsourcing to the private sector - and the explicit remit of the working group is to evaluate and triage the 'increasing number of commercial LFT's' - so while of course plausible, I'd be somewhat surprised...

Equally, your guess is as good as mine!

Also worth a look at the 3 they've already evaluated - https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/lateral-flow-devices-results

Perhaps this is where the '80% sensitivity' figure being bandied around is coming from?

From the LTF introduction:

"On ***15 August 2020***, DHSC Ministers commissioned PHE Porton Down to establish a time-limited SARS-CoV-2 test development and evaluation programme. A scientific team has been established to deliver this work in collaboration with the University of Oxford, PHE Porton Down’s external scientific advisors.

A delivery group, chaired by the Director of PHE Porton Down, will meet daily to direct and co-ordinate the programme. Oversight will be provided by Sir John Bell to ensure that it the work is carried out to appropriate quality and timeliness standards, and to whom progress will be reported at least weekly through an Oversight Group that he chairs."

I find this interesting as Avacta announced it's clinical validation partnership with LSTM on August 6th, nearly two weeks BEFORE the government established an LTF evaluation program.

We have heard it intimated from others (Ophidian et al) that new requirements from Porton Down have been imposed on LTF's as a consequence.

From that excerpt, we can tell this is a program of very high importance to ministers if the Director of Porton Down is to meet DAILY to review progress.

Draw your own conclusions but I don't really believe in coincidences - I suspect this is likely the root of the perceived delay: Avacta are ahead of the government on test development, who have subsequently requested design changes while also holding the company under NDA to allow the Whitehall gears to turn...

The continual misery from Alwayswhining - which is as regular as clockwork regardless of whether the share is up, good news is out or the company is muted.

Everyone is expecting updates - the last day of summer was yesterday ("end of Summer" said Al); tech transfer is ongoing to major manufacturers - and no doubt we will be informed ahead of the forthcoming Investor Presentation of the current state of play.

Lets not allow AW to clog up the board with ****posting to the detriment of meaningful discussion, which is clearly their objective...